Renowned billionaire investor Stanley Druckenmiller is ramping up his asset management firm’s investment in the future of American healthcare.
During the third quarter of 2025, Druckenmiller’s Duquesne Family Office increased its stake in Natera Inc. (NTRA) by 4.19%.
The firm now holds 3,214,532 shares of Natera, valued at $517.4 million, making it the largest holding in the $4.06 billion portfolio, accounting for 12.74% of the total.
This boost added 129,342 shares to their position, as disclosed in the firm’s latest 13F-HR filing with the SEC for the quarter ended September 30, 2025.
Druckenmiller originally invested in Natera when the stock was trading sideways from late 2022 to early 2023. He continued to accumulate shares during a subsequent rally, booked profits in Q1 and Q2 of 2025, and then capitalized on a buying opportunity last quarter.
Natera specializes in non-invasive cell-free DNA testing for oncology, women’s health, and organ health. The company reported an impressive 34.66% year-over-year revenue growth in Q3 2025, surpassing analyst expectations. Natera’s stock has surged over 500% since hitting a low point in October 2023.
Several analysts forecast that Natera’s earnings per share will turn positive by 2028, with double-digit revenue growth anticipated in the coming decade.
Stay updated with our latest news on X, Facebook, and Telegram
Never miss out – Subscribe to receive email alerts directly to your inbox
Explore Price Action
Discover The Daily Hodl Mix
Generated Image: Midjourney
